Suchergebnisse - Zainab Alhamal
- Treffer 1 - 2 von 2
-
1
The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia von Patrick Williams, Sreyashi Basu, Guillermo Garcia‐Manero, Christopher S. Hourigan, Karolyn A. Oetjen, Jorge E. Cortés, Farhad Ravandi, Elias Jabbour, Zainab Alhamal, Marina Konopleva, Jing Ning, Lianchun Xiao, Juliana Hidalgo Lopez, Steve Kornblau, Michael Andreeff, Wilmer Flores, Carlos E. Bueso‐Ramos, Jorge Blando, Pallavi Galera, Katherine R. Calvo, Gheath Alatrash, James P. Allison, Hagop M. Kantarjian, Padmanee Sharma, Naval Daver
Veröffentlicht 2018Artigo -
2
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study von Naval Daver, Guillermo Garcia‐Manero, Sreyashi Basu, Prajwal Boddu, Mansour Alfayez, Jorge E. Cortés, Marina Konopleva, Farhad Ravandi‐Kashani, Elias Jabbour, Tapan M. Kadia, Graciela M. Nogueras‐González, Jing Ning, Naveen Pemmaraju, Courtney D. DiNardo, Michael Andreeff, Sherry Pierce, Tauna Gordon, Steven M. Kornblau, Wilmer Flores, Zainab Alhamal, Carlos E. Bueso‐Ramos, Jeffrey L. Jorgensen, Keyur P. Patel, Jorge Blando, James P. Allison, Padmanee Sharma, Hagop M. Kantarjian
Veröffentlicht 2018Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Immunotherapy
Internal medicine
Leukemia
Medicine
Myeloid leukemia
Oncology
Adverse effect
Astrobiology
Azacitidine
Biochemistry
Bone marrow
Cancer
Cancer research
Chemistry
Chemotherapy
DNA methylation
Distribution (mathematics)
Gastroenterology
Gene
Gene expression
Hypomethylating agent
Immune checkpoint
Immune system
Immunology
Mathematical analysis
Mathematics
Myeloid
Nivolumab
Physics
Progressive disease